ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN

ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN

The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: COOPER, Vincent, Brett, GUPTA, Rajan, PYGALL, Samuel, Robert, BRADLEY, Kathryn, Alanna, STANFORD, Madison, Paige, XIE, Lin
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator COOPER, Vincent, Brett
GUPTA, Rajan
PYGALL, Samuel, Robert
BRADLEY, Kathryn, Alanna
STANFORD, Madison, Paige
XIE, Lin
description The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight of the pharmaceutical formulation and comprises at least one non-reducible sugar diluent or a mixture of non-reducible sugar diluents.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3038465A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3038465A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3038465A43</originalsourceid><addsrcrecordid>eNrjZND3D3L0UQjwcAzydXR2DQ3xdAZy3fyDfEN9HEM8_f0U_N0U_H0dgzzdfTwDQjz9eBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsYGxhYmZqaOJMRFKANffJeM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN</title><source>esp@cenet</source><creator>COOPER, Vincent, Brett ; GUPTA, Rajan ; PYGALL, Samuel, Robert ; BRADLEY, Kathryn, Alanna ; STANFORD, Madison, Paige ; XIE, Lin</creator><creatorcontrib>COOPER, Vincent, Brett ; GUPTA, Rajan ; PYGALL, Samuel, Robert ; BRADLEY, Kathryn, Alanna ; STANFORD, Madison, Paige ; XIE, Lin</creatorcontrib><description>The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight of the pharmaceutical formulation and comprises at least one non-reducible sugar diluent or a mixture of non-reducible sugar diluents.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170426&amp;DB=EPODOC&amp;CC=EP&amp;NR=3038465A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170426&amp;DB=EPODOC&amp;CC=EP&amp;NR=3038465A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COOPER, Vincent, Brett</creatorcontrib><creatorcontrib>GUPTA, Rajan</creatorcontrib><creatorcontrib>PYGALL, Samuel, Robert</creatorcontrib><creatorcontrib>BRADLEY, Kathryn, Alanna</creatorcontrib><creatorcontrib>STANFORD, Madison, Paige</creatorcontrib><creatorcontrib>XIE, Lin</creatorcontrib><title>ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN</title><description>The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight of the pharmaceutical formulation and comprises at least one non-reducible sugar diluent or a mixture of non-reducible sugar diluents.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND3D3L0UQjwcAzydXR2DQ3xdAZy3fyDfEN9HEM8_f0U_N0U_H0dgzzdfTwDQjz9eBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAsYGxhYmZqaOJMRFKANffJeM</recordid><startdate>20170426</startdate><enddate>20170426</enddate><creator>COOPER, Vincent, Brett</creator><creator>GUPTA, Rajan</creator><creator>PYGALL, Samuel, Robert</creator><creator>BRADLEY, Kathryn, Alanna</creator><creator>STANFORD, Madison, Paige</creator><creator>XIE, Lin</creator><scope>EVB</scope></search><sort><creationdate>20170426</creationdate><title>ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN</title><author>COOPER, Vincent, Brett ; GUPTA, Rajan ; PYGALL, Samuel, Robert ; BRADLEY, Kathryn, Alanna ; STANFORD, Madison, Paige ; XIE, Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3038465A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COOPER, Vincent, Brett</creatorcontrib><creatorcontrib>GUPTA, Rajan</creatorcontrib><creatorcontrib>PYGALL, Samuel, Robert</creatorcontrib><creatorcontrib>BRADLEY, Kathryn, Alanna</creatorcontrib><creatorcontrib>STANFORD, Madison, Paige</creatorcontrib><creatorcontrib>XIE, Lin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COOPER, Vincent, Brett</au><au>GUPTA, Rajan</au><au>PYGALL, Samuel, Robert</au><au>BRADLEY, Kathryn, Alanna</au><au>STANFORD, Madison, Paige</au><au>XIE, Lin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN</title><date>2017-04-26</date><risdate>2017</risdate><abstract>The present invention is directed to stable, oral pharmaceutical formulations of dipeptidyl peptidase-4 inhibitors, such as omarigliptin. Such pharmaceutical formulations comprise omarigliptin; and neutral excipients, wherein the neutral excipient is present in the amount of at least 75% by weight of the pharmaceutical formulation and comprises at least one non-reducible sugar diluent or a mixture of non-reducible sugar diluents.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3038465A4
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A05%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COOPER,%20Vincent,%20Brett&rft.date=2017-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3038465A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true